INVO Fertility, Inc.

Stage 4 · Declining · week 90

As of Oct 22, 2026, INVO Fertility is in Stage 4, the downtrend phase, now in week 90 (since Jan 13, 2025). It closed at $0.53, 99.6% below its 52-week high and below its 200-day average, which is falling.

INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. More about the company

$0.53

-8.17% today

$2.5M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is IVF early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 53w

S4 93w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S4 53w → S1 1w → S4 10w → S1 9w → S4 93w current

Total tracked: 166 weeks across 5 stage runs.

IVF among Medical Devices131st of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%
…131	IVFINVO Fertility, Inc.	Stage 4 · wk 90	2	−47.7%

vs 52W High

-99.6%

$0.53 lo$129.20 hi

99.6% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 90

1w13w26w

Week 90, extended decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-82.7%

200 DMA: $3.09 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

0.02x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-47.7%

-46.7%

-75.4%

YTD

-97.6%

-99.5%

Scan Membership

Breakout Watch

Latest: 2021-08-18

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 90 · Vol 0.02x

2026-10-21S4

Wk 90 · Vol 0.03x

2026-10-20S4

Wk 89 · Vol 0.03x

2026-10-19S4

Wk 89 · Vol 0.03x

2026-10-16S4

Wk 89 · Vol 0.03x

2026-10-15S4

Wk 89 · Vol 0.06x

2026-10-14S4

Wk 89 · Vol 0.06x

2026-10-13S4

Wk 88 · Vol 0.08x

2026-10-12S4

Wk 88 · Vol 0.03x

2026-10-09S4

Wk 88 · Vol 0.03x

2026-10-08S4

Wk 88 · Vol 0.03x

2026-10-07S4

Wk 88 · Vol 0.06x

Moving averages & range

50 DMA

$0.91

200 DMA

$3.09

52W High

$129.20

52W Low

$0.53

5D Low

$0.53

Resistance levels (recent highs)

20d High

$0.95

60d High

$1.53

120d High

$2.45

250d High

$115.60

Next resistance

+77.3%

to 20d High

P/E (TTM)

0.0

Forward -0.1

ROE

-72.7%

Profit margin -92.3%

Dividend Yield

0.00%

P/B 0.1

INVO Fertility: quick answers

What stage is INVO Fertility in?

As of Oct 22, 2026, INVO Fertility (IVF) is in Stage 4, the downtrend phase. It entered Stage 4 on Jan 13, 2025 and is in week 90. What the four stages mean

Is INVO Fertility in an uptrend?

No. INVO Fertility is in a Stage 4 downtrend. It trades 82.7% below its 200-day average, which is falling.

How far is INVO Fertility from its 52-week high?

INVO Fertility closed at $0.53 on Oct 22, 2026, 99.6% below its 52-week high of $129.20. Its 52-week low is $0.53.

How has INVO Fertility performed over the past year?

As of Oct 22, 2026, INVO Fertility is down 99.5% over the past year and down 97.6% so far in 2026.

Which sector and industry is INVO Fertility in?

INVO Fertility is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services and INVOcell Device segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.